Skip to main content
. 2017 Jun;102(6):1099–1104. doi: 10.3324/haematol.2016.158303

Figure 2.

Figure 2.

Overall survival according to the circulating plasma cells (PCs) in patients with multiple myeloma and plasma cell leukemia (PCL) treated with novel drugs upfront (P<0.001).